The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Mechanisms of Disease: Inflammatory Bowel Diseases
Open accessAbstract
Inflammatory Bowel Diseases (IBD), represented by Crohn’s Disease (CD) and Ulcerative Colitis (UC), are associated with significant morbidity in western countries and with increasing incidence in the developing world. While analysis of the genome of IBD patients, especially through genome-wide association studies, has unraveled multiple pathways involved in IBD pathogenesis only part of IBD heritability has been explained by genetic studies. This has demonstrated that environmental factors also play a significant role in promoting intestinal inflammation, mostly through their effects in the composition of the microbiome. However, in order for microbial dysbiosis to result in uncontrolled intestinal inflammation, the intestinal barrier formed by intestinal epithelial cells and the innate immune system should also be compromised. Finally, activation of the immune system depends on the working balance between effector and regulatory cells present in the intestinal mucosa, which have also been shown to be dysregulated in this patient population. Therefore, IBD pathogenesis is a result of the interplay of genetic susceptibility, environmental impact on the microbiome that through a weakened intestinal barrier will lead to inappropriate intestinal immune activation. In this review, we will approach the mechanisms proposed to cause IBD from the genetic, environmental, intestinal barrier and the immunologic perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, F. S., & Manolio, T. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903103106 · Cited by 4,013
Antimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Stem Cells, Self-Renewal, and Differentiation in the Intestinal Epithelium
van der Flier, L. G., & Clevers, H. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163145 · Cited by 1,871
Intestinal homeostasis and its breakdown in inflammatory bowel disease
Maloy, K. J., & Powrie, F. (2011) · Nature · doi:10.1038/nature10208 · Cited by 1,870
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,863
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Regulation of inflammation by short chain fatty acids
Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N., Siebert, R., Baron, R. M., Kasper, D. L., et al. (2012) · Science · doi:10.1126/science.1219328 · Cited by 1,661 · cited 1×
“This association usually results from changes in the intestinal microbiome after use of antibiotics during early stages of life, when the microbiota plays a critical role in shaping immune cell development (39).”
BackgroundCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
O'Shea, J. J., Schwartz, D. M., Villarino, A. V., Gadina, M., McInnes, I. B., & Laurence, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051113-024537 · Cited by 1,599
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
Cadwell, K., Liu, J. Y., Brown, S. L., Miyoshi, H., Loh, J., Lennerz, J. K., Kishi, C., Kc, W., Carrero, J. A., Hunt, S., et al. (2008) · Nature · doi:10.1038/nature07416 · Cited by 1,542 · cited 1×
“Patients with ATG16L1and NOD2 mutations, as well equivalent murine models, demonstrate aberrancies in the secretory apparatus of Paneth cells resulting in defects in antibacterial autophagy (77).”
BackgroundInflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Glocker, E.-O., Kotlarz, D., Boztug, K., Gertz, E. M., Schäffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., Allroth, A., Murugan, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907206 · Cited by 1,461
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 1×
“Lastly, the number of sulfate-reducing bacteria, such as Desulfovibrio, is also increased in IBD resulting in the production of hydrogen-sulfate that damages the intestinal barrier and allows activation of mucosal inflammation (57).”
BackgroundTravassos, L. H., Carneiro, L. A. M., Ramjeet, M., Hussey, S., Kim, Y.-G., Magalhães, J. G., Yuan, L., Soares, F., Chea, E., Le Bourhis, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1823 · Cited by 1,306
Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227
Cooney, R., Baker, J., Brain, O., Danis, B., Pichulik, T., Allan, P., Ferguson, D. J. P., Campbell, B. J., Jewell, D., & Simmons, A. (2010) · Nature Medicine · doi:10.1038/nm.2069 · Cited by 1,047
Hou, J. K., Abraham, B., & El-Serag, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.44 · Cited by 1,009 · cited 1×
“Moreover, exposure to diets rich in saturated fatty acids and processed meats has been reported to increase the risk of IBD (32-34).”
BackgroundDenning, T. L., Wang, Y.-C., Patel, S. R., Williams, I. R., & Pulendran, B. (2007) · Nature Immunology · doi:10.1038/ni1511 · Cited by 994
Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine
McDole, J. R., Wheeler, L. W., McDonald, K. G., Wang, B., Konjufca, V., Knoop, K. A., Newberry, R. D., & Miller, M. J. (2012) · Nature · doi:10.1038/nature10863 · Cited by 976
Smythies, L. E., Sellers, M. T., Clements, R. H., Mosteller‐Barnum, M., Meng, G., Benjamin, W. H., Orenstein, J. M., & Smith, P. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci19229 · Cited by 928
Teng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873
Tysk, C., Lindberg, E., Järnerot, G., & Flodérus-Myrhed, B. (1988) · Gut · doi:10.1136/gut.29.7.990 · Cited by 829
Sartor, R. B., & Wu, G. D. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.012 · Cited by 808
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Worthey, E. A., Mayer, A. N., Syverson, G. D., Helbling, D., Bonacci, B. B., Decker, B., Serpe, J. M., Dasu, T., Tschannen, M. R., Veith, R. L., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182088158 · Cited by 711
Familial Occurrence of Inflammatory Bowel Disease
Orholm, M., Munkholm, P., Langholz, E., Nielsen, O. H., Sørensen, T. I. A., & Binder, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101103240203 · Cited by 685
Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D. J., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.017 · Cited by 682
Ananthakrishnan, A. N., Khalili, H., Konijeti, G. G., Higuchi, L. M., de Silva, P., Korzenik, J. R., Fuchs, C. S., Willett, W. C., Richter, J. M., & Chan, A. T. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.050 · Cited by 636
Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M. T., Sugita, A., Koganei, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34610 · Cited by 603
Takahashi, K., Nishida, A., Fujimoto, T., Fujii, M., Shioya, M., Imaeda, H., Inatomi, O., Bamba, S., Andoh, A., & Sugimoto, M. (2016) · Digestion · doi:10.1159/000441768 · Cited by 599
Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases
Hart, A. L., Al-Hassi, H. O., Rigby, R. J., Bell, S. J., Emmanuel, A. V., Knight, S. C., Kamm, M. A., & Stagg, A. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.013 · Cited by 564
Composition and functional role of the mucus layers in the intestine
Johansson, M. E. V., Ambort, D., Pelaseyed, T., Schütte, A., Gustafsson, J. K., Ermund, A., Subramani, D. B., Holmén-Larsson, J. M., Thomsson, K. A., Bergström, J. H., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0822-3 · Cited by 556
Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease
Ananthakrishnan, A. N., Khalili, H., Konijeti, G. G., Higuchi, L. M., de Silva, P., Fuchs, C. S., Willett, W. C., Richter, J. M., & Chan, A. T. (2014) · Gut · doi:10.1136/gutjnl-2013-305304 · Cited by 516
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503
Shaw, S. Y., Blanchard, J. F., & Bernstein, C. N. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.398 · Cited by 483
Jowett, S. L., Seal, C. J., Pearce, M. S., Phillips, E., Gregory, W., Barton, J. R., & Welfare, M. R. (2004) · Gut · doi:10.1136/gut.2003.024828 · Cited by 462
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
Weaver, C. T., Elson, C. O., Fouser, L. A., & Kolls, J. K. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130318 · Cited by 462
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Vermeire, S., O'Byrne, S., Keir, M., Williams, M., Lu, T. T., Mansfield, J. C., Lamb, C. A., Feagan, B. G., Panes, J., Salas, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60661-9 · Cited by 452
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., Wolf, D. C., D’Haens, G., Vermeire, S., Hanauer, S. B., Ghosh, S., Smith, H., Cravets, M., Frohna, P. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513248 · Cited by 452
Primary immunodeficiencies: 2009 update
Notarangelo, L. D., Fischer, A., Geha, R. S., Casanova, J.-L., Chapel, H., Conley, M. E., Cunningham-Rundles, C., Etzioni, A., Hammartröm, L., Nonoyama, S., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.013 · Cited by 447
Ng, S. C., Tang, W., Leong, R. W., Chen, M., Ko, Y., Studd, C., Niewiadomski, O., Bell, S., Kamm, M. A., de Silva, H. J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307410 · Cited by 443 · cited 1×
“Early life events such as mode of delivery, breast feeding, exposure to pets and infections (“hygiene hypothesis”) are also factors associated with significant risk of development of IBD, mostly given influences in the composition of the intestinal microbiota (43-46).”
BackgroundParamsothy, S., Paramsothy, R., Rubin, D. T., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., & Castaño-Rodríguez, N. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx063 · Cited by 436
Genetics of Inflammatory Bowel Diseases
McGovern, D. P. B., Kugathasan, S., & Cho, J. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.001 · Cited by 431
Salzman, N. H., Underwood, M. A., & Bevins, C. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.04.002 · Cited by 414 · cited 2×
“While Goblet-cells seem to play a part in protecting from colitis developement, defects in Paneth Cell biology are associated with increased risk for CD (72, 73).”
BackgroundSmith, A. M., Rahman, F. Z., Hayee, B., Graham, S. J., Marks, D. J. B., Sewell, G. W., Palmer, C. D., Wilde, J., Foxwell, B. M. J., Gloger, I. S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091233 · Cited by 398
Buhner, S., Buning, C., Genschel, J., Kling, K., Herrmann, D., Dignass, A., Kuechler, I., Krueger, S., Schmidt, H. H.-J., & Lochs, H. (2006) · Gut · doi:10.1136/gut.2005.065557 · Cited by 368
Inflammatory bowel disease is associated with changes of enterocytic junctions
Gassler, N., Rohr, C., Schneider, A., Kartenbeck, J., Bach, A., Obermüller, N., Otto, H. F., & Autschbach, F. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.1.g216 · Cited by 365
Selby, W., Pavli, P., Crotty, B., Florin, T., Radford-Smith, G., Gibson, P., Mitchell, B., Connell, W., Read, R., Merrett, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.031 · Cited by 362
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation
Cader, M. Z., & Kaser, A. (2013) · Gut · doi:10.1136/gutjnl-2012-303955 · Cited by 337
Uhlig, H. H. (2013) · Gut · doi:10.1136/gutjnl-2012-303956 · Cited by 335
Kuballa, P., Huett, A., Rioux, J. D., Daly, M. J., & Xavier, R. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003391 · Cited by 328
Medina-Contreras, O., Geem, D., Laur, O., Williams, I. R., Lira, S. A., Nusrat, A., Parkos, C. A., & Denning, T. L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59150 · Cited by 325
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90638-s · Cited by 314
Schultsz, C., van den Berg, F. M., ten Kate, F. W., Tytgat, G. N. J., & Dankert, J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70393-8 · Cited by 312
Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease
Fujimoto, T., Imaeda, H., Takahashi, K., Kasumi, E., Bamba, S., Fujiyama, Y., & Andoh, A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12073 · Cited by 304
Söderholm, J. D., Olaison, G., Peterson, K. H., Franzén, L. E., Lindmark, T., Wirén, M., Tagesson, C., & Sjödahl, R. (2002) · Gut · doi:10.1136/gut.50.3.307 · Cited by 289
Irvine, E. J., & Marshall, J. K. (2000) · Gastroenterology · doi:10.1053/gast.2000.20231 · Cited by 286
XIAP mediates NOD signaling via interaction with RIP2
Krieg, A., Correa, R. G., Garrison, J. B., Le Negrate, G., Welsh, K., Huang, Z., Knoefel, W. T., & Reed, J. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907131106 · Cited by 286
Intestinal epithelial cell secretion of RELM-β protects against gastrointestinal worm infection
Herbert, D. R., Yang, J.-Q., Hogan, S. P., Groschwitz, K., Khodoun, M., Munitz, A., Orekov, T., Perkins, C., Wang, Q., Brombacher, F., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091268 · Cited by 283
Ananthakrishnan, A. N., Higuchi, L. M., Huang, E. S., Khalili, H., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-5-201203060-00007 · Cited by 262
Varela, E., Manichanh, C., Gallart, M., Torrejón, A., Borruel, N., Casellas, F., Guarner, F., & Antolin, M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12365 · Cited by 249
Crohn's disease: NOD2, autophagy and ER stress converge
Fritz, T., Niederreiter, L., Adolph, T., Blumberg, R. S., & Kaser, A. (2011) · Gut · doi:10.1136/gut.2009.206466 · Cited by 230
Intestinal macrophages: unique effector cells of the innate immune system
Smith, P. D., Ochsenbauer‐Jambor, C., & Smythies, L. E. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00288.x · Cited by 228
Oral contraceptives, reproductive factors and risk of inflammatory bowel disease
Khalili, H., Higuchi, L. M., Ananthakrishnan, A. N., Richter, J. M., Feskanich, D., Fuchs, C. S., & Chan, A. T. (2013) · Gut · doi:10.1136/gutjnl-2012-302362 · Cited by 221
Identification of an Autophagy Defect in Smokers’ Alveolar Macrophages
Monick, M. M., Powers, L. S., Walters, K., Lovan, N., Zhang, M., Gerke, A., Hansdottir, S., & Hunninghake, G. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001603 · Cited by 214
Allais, L., Kerckhof, F., Verschuere, S., Bracke, K. R., De Smet, R., Laukens, D., Van den Abbeele, P., De Vos, M., Boon, N., Brusselle, G. G., et al. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.12934 · Cited by 195
Microbiome, Metabolome and Inflammatory Bowel Disease
Ahmed, I., Roy, B., Khan, S., Septer, S., & Umar, S. (2016) · Microorganisms · doi:10.3390/microorganisms4020020 · Cited by 193
Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis
Yu, Q. T., Saruta, M., Avanesyan, A., Fleshner, P. R., Banham, A. H., & Papadakis, K. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20053 · Cited by 192
Self-citationEpidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study
Spehlmann, M. E., Begun, A. Z., Burghardt, J., Lepage, P., Raedler, A., & Schreiber, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20380 · Cited by 189
Cesarean section and offspringʼs risk of inflammatory bowel disease: A national cohort study
Bager, P., Simonsen, J., Nielsen, N. M., & Frisch, M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21805 · Cited by 185
The Role of Environmental Factors in the Pathogenesis of Inflammatory Bowel Diseases: A Review
Shouval, D. S., & Rufo, P. A. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.2571 · Cited by 174
Pabst, O., Zweigerdt, R., & Arnold, H.-H. (1999) · Development · doi:10.1242/dev.126.10.2215 · Cited by 171
Danese, S., Rudziński, J., Brandt, W., Dupas, J., Peyrin‐Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukáš, M., Knutsson, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-308004 · Cited by 170
Muise, A. M., Walters, T. D., Glowacka, W. K., Griffiths, A. M., Ngan, B., Lan, H., Xu, W., Silverberg, M. S., & Rotin, D. (2009) · Gut · doi:10.1136/gut.2008.175117 · Cited by 165
Reinisch, W., Panés, J., Khurana, S., Toth, G., Hua, F., Comer, G. M., Hinz, M., Page, K. M., O’Toole, M., Moorehead, T. M., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308337 · Cited by 163
van der Waaij, L. A., Harmsen, H. J. M., Madjipour, M., Kroese, F. G. M., Zwiers, M., van Dullemen, H. M., de Boer, N. K., Welling, G. W., & Jansen, P. L. M. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000179212.80778.d3 · Cited by 157
Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answers
Himmel, M. E., Yao, Y. F., Orban, P. C., Steiner, T. S., & Levings, M. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03572.x · Cited by 146
Epidemiology, Natural History, and Risk Stratification of Crohn's Disease
Aniwan, S., Park, S. H., & Loftus, E. V. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.05.003 · Cited by 140
Darsigny, M., Babeu, J., Dupuis, A.-A., Furth, E. E., Seidman, E. G., Levy, E. H., Verdu, E. F., Gendron, F., & Boudreau, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007609 · Cited by 137
Rescigno, M. (2010) · Advances in immunology · doi:10.1016/b978-0-12-381300-8.00004-6 · Cited by 133
Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
Cholapranee, A., & Ananthakrishnan, A. N. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000852 · Cited by 119
Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Dave, M., Mehta, K. D., Luther, J., Baruah, A., Dietz, A. B., & Faubion, W. A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000543 · Cited by 117
Characteristics of Inflammatory Bowel Disease With Onset During the First Year of Life
Ruemmele, F. M., Khoury, M. G. E., Talbotec, C., Maurage, C., Mougenot, J., Schmitz, J., & Goulet, O. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000237938.12674.e3 · Cited by 117
The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation
Shaw, M. H., Kamada, N., Warner, N. E., Kim, Y., & Núñez, G. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.12.007 · Cited by 115
The Influence of Cigarette Smoking on Cytokine Levels in Patients with Inflammatory Bowel Disease
Sher, M. E., Bank, S., Greenberg, R., Sardinha, T. C., Weissman, S., Bailey, B., Gilliland, R., & Wexner, S. D. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199905000-00001 · Cited by 109
Danese, S., & Panés, J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.044 · Cited by 98
Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis
McVay, L. D., Keilbaugh, S. A., Wong, T., Kierstein, S., Shin, M. E., Lehrke, M., Lefterova, M. I., Shifflett, D. E., Barnes, S. L., Cominelli, F., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28121 · Cited by 96
Paramsothy, S., Paramsothy, R., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., Rubin, D. T., & Castaño‐Rodríguez, N. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)33417-0 · Cited by 87
Briakinumab for Treatment of Crohnʼs Disease
Panaccione, R., Sandborn, W. J., Gordon, G. L., Lee, S. D., Safdi, A. V., Sedghi, S., Feagan, B. G., Hanauer, S. B., Reinisch, W., Valentine, J. F., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000366 · Cited by 82
Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease
Kvasnovsky, C., Aujla, U. I., & Bjarnason, I. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.966753 · Cited by 81
Chu, K., Watermeyer, G., Shelly, L. J., Janssen, J. M., May, T. D., Brink, K., Benefeld, G., & Li, X. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31827f27f4 · Cited by 66
Jovani, M., & Danese, S. (2013) · Current Drug Targets · doi:10.2174/13894501113146660206 · Cited by 64
Itoh, H., Beck, P. L., Inoue, N., Xavier, R. J., & Podolsky, D. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6211 · Cited by 62
Metabolome and inflammasome in inflammatory bowel disease
Nanau, R. M., & Neuman, M. G. (2011) · Translational research · doi:10.1016/j.trsl.2011.08.006 · Cited by 31
Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes
Galien, R. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.04.001 · Cited by 27
Cited by
Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
Sinha, S. R., Haileselassie, Y., Nguyen, L. P., Tropini, C., Wang, M., Becker, L. S., Sim, D., Jarr, K., Spear, E. T., Singh, G., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.021 · Cited by 852
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
Deleu, S., Machiels, K., Raes, J., Verbeke, K., & Vermeire, S. (2021) · eBioMedicine · doi:10.1016/j.ebiom.2021.103293 · Cited by 766
Wu, Z., Huang, S., Li, T., Li, N., Han, D., Zhang, B., Xu, Z. Z., Zhang, S., Pang, J., Wang, S., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01115-9 · Cited by 693
Zhang, M., Ma, Y., Ye, X., Zhang, N., Pan, L., & Wang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01464-x · Cited by 522
Hays, K. E., Pfaffinger, J. M., & Ryznar, R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393270 · Cited by 453
Metadata
- Authors
- Ramos, G. P., & Papadakis, K. A.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 94
- Issue
- 1
- Pages
- 155-165
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2906727442
- Cited by
- 1,021
- References
- 118
- FWCI
- 51.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.